VALENTINI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 4.476
AS - Asia 2.730
EU - Europa 2.383
SA - Sud America 304
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 57
OC - Oceania 6
Totale 10.052
Nazione #
US - Stati Uniti d'America 4.306
CN - Cina 1.439
SG - Singapore 530
IE - Irlanda 521
UA - Ucraina 337
FI - Finlandia 293
HK - Hong Kong 268
DE - Germania 263
RU - Federazione Russa 231
BR - Brasile 220
VN - Vietnam 198
IT - Italia 183
FR - Francia 147
SE - Svezia 144
GB - Regno Unito 130
CA - Canada 77
IN - India 76
ZA - Sudafrica 49
AR - Argentina 34
BE - Belgio 31
ID - Indonesia 30
MX - Messico 25
NL - Olanda 25
JP - Giappone 24
BD - Bangladesh 23
TR - Turchia 22
IQ - Iraq 21
ES - Italia 17
PK - Pakistan 14
PL - Polonia 14
SA - Arabia Saudita 12
CO - Colombia 11
CW - ???statistics.table.value.countryCode.CW??? 10
IL - Israele 10
MA - Marocco 10
NI - Nicaragua 10
UZ - Uzbekistan 9
EC - Ecuador 8
IR - Iran 8
TT - Trinidad e Tobago 8
CZ - Repubblica Ceca 7
PR - Porto Rico 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CR - Costa Rica 6
GP - Guadalupe 6
HN - Honduras 6
JM - Giamaica 6
LT - Lituania 6
MY - Malesia 6
PE - Perù 6
AT - Austria 5
AU - Australia 5
GT - Guatemala 5
JO - Giordania 5
LV - Lettonia 5
SC - Seychelles 5
BO - Bolivia 4
DZ - Algeria 4
MU - Mauritius 4
NG - Nigeria 4
PA - Panama 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
TN - Tunisia 4
AL - Albania 3
BB - Barbados 3
EG - Egitto 3
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
SN - Senegal 3
UY - Uruguay 3
AG - Antigua e Barbuda 2
AZ - Azerbaigian 2
BS - Bahamas 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
KE - Kenya 2
MD - Moldavia 2
NP - Nepal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
EE - Estonia 1
EU - Europa 1
GM - Gambi 1
GY - Guiana 1
Totale 9.993
Città #
Dublin 520
Chandler 505
Ashburn 416
San Jose 376
Jacksonville 373
Beijing 298
Nanjing 270
Hong Kong 261
Singapore 254
Council Bluffs 180
Dallas 173
Ann Arbor 152
Boardman 147
Nanchang 131
Los Angeles 121
Helsinki 108
Wilmington 104
New York 90
Lawrence 85
Medford 85
Princeton 85
Shenyang 76
Lauterbourg 72
Changsha 70
Hebei 70
Munich 68
Ho Chi Minh City 62
Jiaxing 62
Tianjin 62
Hangzhou 61
Hanoi 51
Shanghai 51
Johannesburg 43
Buffalo 42
Milan 42
Woodbridge 39
Santa Clara 38
Moscow 36
São Paulo 33
Brussels 30
Verona 26
Orem 25
Tokyo 21
Turku 21
Brooklyn 18
Chicago 18
Toronto 18
Atlanta 17
Chennai 17
Denver 17
Redondo Beach 17
Frankfurt am Main 15
Montreal 15
Norwalk 15
Dearborn 14
Falls Church 14
Pavia 14
Phoenix 14
Boston 13
London 12
Auburn Hills 11
Da Nang 11
Houston 11
Jinan 11
Mexico City 11
The Dalles 11
Warsaw 11
Haiphong 10
Mumbai 10
Piscataway 10
Seattle 10
Willemstad 10
Des Moines 9
Fairfield 9
Managua 9
Stockholm 9
Tappahannock 9
Tashkent 9
Amsterdam 8
Buenos Aires 8
San Francisco 8
Ankara 7
Columbus 7
Curitiba 7
Kunming 7
Lahore 7
Rio de Janeiro 7
Taizhou 7
Vienna 7
Baghdad 6
Bari 6
Jakarta 6
Manchester 6
Naples 6
Ningbo 6
Nuremberg 6
Roubaix 6
Sacramento 6
Calgary 5
Chaguanas 5
Totale 6.408
Nome #
Absence of interaction between doppel and GFAP, Grb2, PrPC proteins in human tumor astrocytic cells 178
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 177
The prion-like doppel protein is soluble in astrocytic tumor 164
Aberrant Doppel Protein Expression in Human Astrocytic Tumors 162
Letter to the editor regarding Shibayama et al.: Biochemical and pathophysiological characterization of Helicobacter pylori asparaginase. 158
Divergent biding sites in pyruvate kinase I and II from Escherichia coli. 157
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 154
A new mutation of the pgk1 gene detected in an italian patient affected by phosphoglycerate kinase deficiency. 149
Primary structure of three peptides at the catalytic and allosteric sites of the fructose 1,6-bisphosphate-activated pyruvate kinase from Escherichia coli 147
An essential lysine in the substrate-binding of ornithine carbamoyl transferase 146
Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants 146
Generation of Mutants of Helicobacter pylori L-Asparaginase 145
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 144
Phosphoglycerate Kinase Deficiency: Characterization of the Wild-Type Enzyme and Three Pathological Variants Generated from C.140T>a, C.491A>T and C.959G>a Mutations 142
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli: ligands promoted conformational changes 141
Biochemistry of Lipolytic Enzymes Secreted by Penicillium solitum and Cladosporium cladosporioides 141
Helicobacter pylori L-asparaginase: from Gene to Diagnostic Tool 140
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 140
A simple procedure for the purification of neutral salt soluble type I collagene from skin. 140
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 139
Crystallization and preliminary X-ray analysis of pyruvate kinase type I from Escherichia coli. 139
Expanding targets for a metabolic therapy of cancer: L-asparaginase 136
Helicobacter pylori: from gene to Diagnostic Tool 134
Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition 134
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 132
The allosteric regulation of pyruvate kinase. 132
Molecular Insights on Pathogenic Effects of MutationsCausing Phosphoglycerate Kinase Deficiency 131
Two forms of pyruvate kinase in Escherichia coli. A comparison of chemical and molecular properties 129
Affinity labelling of the catalytic and allosteric ATP binding sites on pyruvate kinase type I from Escherichia coli. 129
Expanding Targets for a Metabolic Therapy of Cancer: L- Asparaginase 129
Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene. 129
AMP- and fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. 128
SELECTION OF MICROFUNGI WITH HIGH LIPOLYTIC ACTIVITYAND THEIR LIPASE CHARACTERIZATION 128
Bacterial pyruvate kinases have a shorter N-terminal domain 128
Recombinant pyruvate kinase type I from Escherichia coli:overproduction and revised C-terminus of the polypeptide 127
Biochemical signatures of doppel (Dpl) protein in human glioblastoma to support prediction in tumor malignancy 127
Pyruvate kinase deficiency: Biochemical characterization of two mutations causing inability of the enzyme to properly bind substrates 126
Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells 126
A comparative study on liver ornithine carbamoyl transferase from a marine mammal Stenella and a elasmobranch Sphyrna zygaena. 125
Rapid detection of ornithine transcarbamylase activity by micellar electrokinetic chromatography. 123
Influence of fibronectine on the fibrillogenesis of type I and type III collagen 123
PYRUVATE KINASE DEFICIENCY: MOLECULAR AND FUNCTIONAL CHARACTERISATION OF A LETHAL VARIANT 122
PHOSPHOGLYCERATE KINASE DEFICIENCY: FUNCTIONAL PROPERTIES OF THE L89P, K191DEL, C316R AND A354P PATHOLOGICAL VARIANTS 120
Characterization of a pyrimidine 5'-nucleotidase mutant form (G214R) causing hereditary hemolytic anemia. 120
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. Natures of bonds involved in the allosteric mecchanism. 118
Reactivity of the fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli with pyridoxal 5’-phosphate 118
Molecular cloning and characterisation of Helicobacter pylori L-asparaginase 118
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. 118
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia 117
Micellar electrokinetic chromatography as a complementary method to sodium dodecyl sulfate-polyacrylamide gel electrophoresis for studying limited proteolysis of proteins. 117
Premio Ricercatissimi 2008 110
Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia 109
Investigating the Molecular Bases of the Phosphoglycerate Kinase Deficiency: Characterization ofG158V, R206P, V266M and D285V Pathological Variants. 108
Molecular basis of pyrimidine 5'-nucleotidase deficiency caused by 3 newly identified missense mutations (c.187T>C, c.469G>C and c.740T>C) and a tabulation of known mutations 107
Molecular Characterization of Three New Mutant Enzymes of Pyrimidine 5-Nucleotidase Causing Hereditary Hemolytic Anemia. 104
Human erythrocyte pyruvate kinase:characterization of the recombinant enzyme and a mutant form(R510Q))causing nonspherocytic hemolytic anemia. 103
EXPRESSION AND CHARACTERIZATION OF THE BOVINE PRION DOPPEL 102
Pyrimidine 5' Nucleotidase Deficiency: Clinical and Molecular Characterization of Two New Italian Patients 102
Erythrocyte Adenylate Kinase Deficiency: First In-Depth Biochemical Characterization of the Y164C Mutant Enzyme Causing Hemolytic Anemia 101
Aeroplane shaped crystal of a mutant ofHelicobacter pylori L-asparaginase. 101
Purification and molecular properties of the AMP-activated pyruvate kinase from Escherichia coli. 100
Molecular and functional characterization of a lethal variant of pyruvate kinase deficiency 99
Pyrimidine 5'-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography. 99
Red cell pyruvate kinase deficiency: molecular and clinical aspects 99
Molecular Basis of Hemolytic Anemia: First Biochemical Characterization of Wild-Type and N190S Mutant Human Erythrocyte Pyrimidine 5'-Nucleotidase. 97
Functional and structural characterization of ovine ornithine transcarbamoylase 96
Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations. 95
Inosine monophosphate dehydrogenase activity after mycophenolate mofetil in renal transplant patients receiving different immunosupressive combined therapy and stable after at least three months' administration. 95
Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene 95
Structural and Energetic Basis of Protein Kinetic Destabilization in Human Phosphoglycerate Kinase 1 Deficiency 95
Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview 93
Pyruvate kinase deficiency : The genotype-phenotype association 93
Molecular Cloning and Characterisation of Helicobacter Pylori L-Asparaginase: A Cytotoxic Factor with Potential Biomedical Applications 93
The allosteric regulation of pyruvate kinase 92
Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia 90
Protein Stability, Folding and Misfolding in Human PGK1 Deficiency 90
Functional Analysis of Two Mutants of Pyrimidine 5’ Nucleotidase Causing Nonspherocytic Hemolytic Anemia 88
Two new mutations of the P5'N-1 gene found in Italian patients with hereditary hemolytic anemia: the molecular basis of the red cell enzyme disorder. 87
L-ASPARAGINASE FROM HELICOBACTER PYLORI 87
The interplay between protein stability and folding co-operativity in loss-of-function genetic disease: The case of human PGK1 deficiency. 84
Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase 82
Monitoring Inosine monophosphate dehydrogenase (IMPDH) in kidney transplant recipients 75
Helicobacter pylori L-asparaginase: A promising chemotherapeutic agent 75
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy 70
Protein stability, folding and misfolding in human PGK1 deficiency 43
Totale 10.052
Categoria #
all - tutte 40.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022422 0 0 0 0 26 17 15 32 32 20 51 229
2022/20231.411 124 122 9 128 157 155 1 64 594 8 32 17
2023/2024516 121 70 6 43 50 141 7 32 0 12 20 14
2024/20251.228 28 97 45 44 32 52 41 73 322 23 179 292
2025/20262.917 234 197 300 370 357 162 502 111 304 210 86 84
2026/2027959 50 156 253 352 148 0 0 0 0 0 0 0
Totale 10.052